Deconstructing 21 CFR Part 111 cGMP Audits & USP 2232 Assays

What Current Good Manufacturing Practices (cGMP) Entail

The Code of Federal Regulations title 21, Part 111 (21 CFR Part 111) outlines mandatory requirements for manufacturers of dietary supplements. Compliance requires automated environmental monitoring, documented cleaning validations between production runs, and comprehensive Master Batch Records (MBR) detailing every step from raw powder blending to induction sealing. {PRODUCT_NAME} is manufactured in a facility that undergoes regular third-party audits to maintain verified cGMP certification.

USP 2232 Heavy Metal Tolerance Limits

Agricultural and botanical ingredients naturally absorb trace minerals from soil. To ensure safety, the United States Pharmacopeia standard USP 2232 establishes strict permissible daily exposure (PDE) limits for elemental impurities. Using Inductively Coupled Plasma Mass Spectrometry (ICP-MS), our quality control teams verify that finished {PRODUCT_NAME} capsules contain less than 0.005 ppm of lead and arsenic, and less than 0.002 ppm of cadmium and mercury—well below federal thresholds.

Certificate of Analysis (COA) Transparency

Every production run of {PRODUCT_NAME} is assigned a unique batch code (such as active batch #{BATCH_CODE}) and matched with a physical Certificate of Analysis. The COA documents HPLC active compound potency, microbial absence, and dissolution testing times. This data is archived in our domestic ledger and can be reviewed via our interactive authenticity portal at any time.